
Austin Murata
Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )
| Most Active Art Unit | 1712 |
| Art Unit(s) | 1792, 1712 |
| Total Applications | 876 |
| Issued Applications | 484 |
| Pending Applications | 86 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5827854
[patent_doc_number] => 20060063172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample'
[patent_app_type] => utility
[patent_app_number] => 11/147714
[patent_app_country] => US
[patent_app_date] => 2005-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9419
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147714 | Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample | Jun 6, 2005 | Abandoned |
Array
(
[id] => 5799302
[patent_doc_number] => 20060034835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Immunoglobulin variants and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/147780
[patent_app_country] => US
[patent_app_date] => 2005-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 36898
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147780 | Immunoglobulin variants and uses thereof | Jun 6, 2005 | Issued |
Array
(
[id] => 6930778
[patent_doc_number] => 20050281812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Antibodies to insulin-like growth factor I receptor'
[patent_app_type] => utility
[patent_app_number] => 11/144222
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 36290
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11144222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/144222 | Antibodies to insulin-like growth factor I receptor | Jun 1, 2005 | Issued |
Array
(
[id] => 4564636
[patent_doc_number] => 07858092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Neovascular-targeted immunoconjugates'
[patent_app_type] => utility
[patent_app_number] => 11/134428
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 15163
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134428
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134428 | Neovascular-targeted immunoconjugates | May 22, 2005 | Issued |
Array
(
[id] => 5177046
[patent_doc_number] => 20070178106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Compositions and methods for enhancing nk cell activity'
[patent_app_type] => utility
[patent_app_number] => 11/587890
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17147
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178106.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587890 | Compositions and methods for enhancing nk cell activity | Apr 28, 2005 | Abandoned |
Array
(
[id] => 5613554
[patent_doc_number] => 20060115482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Modifications of histone proteins as indicators of cell proliferation and differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/116142
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30968
[patent_no_of_claims] => 127
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116142 | Modifications of histone proteins as indicators of cell proliferation and differentiation | Apr 25, 2005 | Abandoned |
Array
(
[id] => 5303401
[patent_doc_number] => 20090298053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples'
[patent_app_type] => utility
[patent_app_number] => 11/587336
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23559
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298053.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587336 | Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples | Apr 20, 2005 | Abandoned |
Array
(
[id] => 7135937
[patent_doc_number] => 20050180960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Alginate capsules for use in the treatment of brain tumour'
[patent_app_type] => utility
[patent_app_number] => 11/104245
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9212
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20050180960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104245 | Alginate capsules for use in the treatment of brain tumour | Apr 10, 2005 | Abandoned |
Array
(
[id] => 7050313
[patent_doc_number] => 20050186200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'HADHs as modifiers of the p21 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/103068
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12956
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186200.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103068
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103068 | HADHs as modifiers of the p21 pathway and methods of use | Apr 10, 2005 | Abandoned |
Array
(
[id] => 177527
[patent_doc_number] => 07655234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/097912
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 33
[patent_no_of_words] => 73765
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097912 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Mar 31, 2005 | Issued |
Array
(
[id] => 246754
[patent_doc_number] => 07585505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/097864
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 33
[patent_no_of_words] => 73657
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097864 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Mar 31, 2005 | Issued |
Array
(
[id] => 7220387
[patent_doc_number] => 20050260710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Methods for producing recombinant polyclonal immunoglobulins'
[patent_app_type] => utility
[patent_app_number] => 11/092988
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11119
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092988
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092988 | Methods for producing recombinant polyclonal immunoglobulins | Mar 29, 2005 | Abandoned |
Array
(
[id] => 5016166
[patent_doc_number] => 20070259375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Biomarkers and Methods for Determining Sensitivity to Epidermal Growth Factor Receptor Modulators in Non-Small Cell Lung Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/594211
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19307
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594211 | Biomarkers and Methods for Determining Sensitivity to Epidermal Growth Factor Receptor Modulators in Non-Small Cell Lung Cancer | Mar 27, 2005 | Abandoned |
Array
(
[id] => 5165278
[patent_doc_number] => 20070286862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Cancer Associated Antigens'
[patent_app_type] => utility
[patent_app_number] => 10/594791
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6280
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20070286862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594791
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594791 | Cancer Associated Antigens | Mar 23, 2005 | Abandoned |
Array
(
[id] => 5029041
[patent_doc_number] => 20070270488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Treatment and Assays'
[patent_app_type] => utility
[patent_app_number] => 10/592282
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13828
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270488.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592282 | Treatment and Assays | Mar 13, 2005 | Abandoned |
Array
(
[id] => 6957841
[patent_doc_number] => 20050214211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/073349
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 69313
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073349 | Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer | Mar 2, 2005 | Abandoned |
Array
(
[id] => 7256031
[patent_doc_number] => 20050143308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation'
[patent_app_type] => utility
[patent_app_number] => 11/064496
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25249
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064496 | Survivin, a protein that inhibits cellular apoptosis, and its modulation | Feb 23, 2005 | Abandoned |
Array
(
[id] => 5148264
[patent_doc_number] => 20070048323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Antibody treatment of lipomatous tumors'
[patent_app_type] => utility
[patent_app_number] => 11/374284
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5016
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11374284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/374284 | Antibody treatment of lipomatous tumors | Feb 17, 2005 | Abandoned |
Array
(
[id] => 7730132
[patent_doc_number] => 08101722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-24
[patent_title] => 'Less immunogenic binding molecules'
[patent_app_type] => utility
[patent_app_number] => 10/588734
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 11
[patent_no_of_words] => 13761
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/101/08101722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588734 | Less immunogenic binding molecules | Feb 15, 2005 | Issued |
Array
(
[id] => 5084931
[patent_doc_number] => 20070274982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Anti-EpCam Immunoglobulins'
[patent_app_type] => utility
[patent_app_number] => 10/589450
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10574
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589450 | Anti-EpCam Immunoglobulins | Feb 8, 2005 | Abandoned |